Ripretinib (QINLOCK®) According to Current SmPC

Clinical trial NCT06619275 · COMPLETED

Trial details

NCT number: NCT06619275
Sponsor: iOMEDICO AG
Status: COMPLETED
Study type: OBSERVATIONAL

GIST - Gastrointestinal Stromal Tumor

Start date: 2024-10-17
Primary completion: 2025-08-15
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.